Dry Eye After
Cataract Surgery:
Why It Happens
and What Actually Helps
More than 1 in 3 people who have cataract surgery come out the other side with dry eyes. Not because something went wrong — but because of what surgery, by its very nature, does to the corneal nerves. Here's the full picture.
post-surgery (meta-analysis, 2022)
follow-up for dry eye symptoms
post-operatively
corneal nerves regenerate
- 1What dry eye after surgery actually is
- 2The corneal nerve — why surgery causes it
- 3How common it is: the real numbers
- 4Risk factors — who is most vulnerable
- 5Symptoms and vision impact
- 6What actually helps — treatment evidence
- 7What surgeons know (that patients often don't)
- 8Frequently asked questions
First, an honest admission
Cataract surgery has a 99%+ success rate. It restores vision. It is genuinely one of medicine's great miracles. And for more than a third of patients, it also causes dry eye.
These two things can both be true. A surgery can go perfectly and still leave a patient with gritty, burning, light-sensitive eyes for weeks or months. Understanding why this happens — the actual biology — changes how patients experience recovery and how surgeons manage expectations.
Dry eye after cataract surgery is not a complication in the traditional sense. It is not a sign that something went wrong. It is a predictable, physiologically explicable consequence of what every cataract surgery, no matter how skilled the surgeon, does to the corneal nervous system.
This article covers the mechanism, the numbers, the risk factors, and the treatments — drawing on peer-reviewed research from 2022 through 2026 rather than generic aftercare advice.
The corneal nerve: surgery's
unavoidable disruption
The cornea has the highest density of sensory nerve endings of any tissue in the human body. Every cataract incision — however small — cuts through some of them.
To understand why dry eye occurs after cataract surgery, you need to understand what those corneal nerves actually do. They are not there only for sensation. They form a feedback loop: they sense whether the ocular surface is dry, and if it is, they send signals to the lacrimal gland to produce more tears, and to the brain to trigger a blink.
When a surgeon makes a clear corneal incision — even a modern micro-incision of 2.0–2.8mm — those radial stromal nerve fibres at the incision site are severed. The feedback loop is interrupted. The lacrimal gland receives less signal. Reflex tearing drops. Blink frequency decreases without the normal neural prompts.
"Gather a group of patients who are prone to dry eye due to their age and co-existing systemic health issues. Now cut their corneal nerves, create inflammation, and then induce more ocular surface disruption via topical pharmaceuticals. Is there any wonder why these patients complain of dry eyes, ocular irritation, and foreign body sensation after cataract surgery?"
Four mechanisms operating simultaneously
Post-cataract dry eye is multifactorial. These factors compound each other.
SICS vs Phacoemulsification: incision size matters
Manual small incision cataract surgery (SICS), which uses a 5–7mm corneoscleral tunnel, severs a larger arc of corneal nerves than modern phacoemulsification (1.8–2.8mm). Studies consistently show higher dry eye prevalence and severity in the first weeks after SICS. However, phacoemulsification is not free of nerve disruption — even micro-incision techniques reduce corneal sensitivity measurably for up to 3 months post-operatively.
How common is it —
the actual numbers
Here is what the peer-reviewed literature says, as of 2025–2026:
37.4% — That is the pooled prevalence of dry eye disease in patients without pre-existing DED who underwent cataract surgery, from a systematic review and meta-analysis by Miura et al. published in Ophthalmology and Therapy (2022), which included nine studies covering 775 patients. Overall 37.4% (95% CI 22.6–52.3) of patients without preexisting DED developed dry eye disease after cataract surgery.
A separate 2025 meta-analysis from the University of Colorado (Ta et al., BMC Ophthalmology) confirmed that dry eye severity usually peaks at one week after cataract surgery and may persist for up to three months postoperatively.
From a healthcare utilisation standpoint, nearly 1 in 5 patients had dry eye symptoms post-cataract surgery requiring non-routine follow-up, with 1 in 12 needing more than one extra appointment — representing significant clinical burden beyond the expected recovery pathway.
The underdiagnosis problem
Dry eye is significantly underdiagnosed before cataract surgery. Many patients presenting for cataract evaluation already have subclinical DED that has not been identified. A 2018 study by Gupta et al. (Journal of Cataract and Refractive Surgery) found that 77% of patients presenting for cataract evaluation had signs of ocular surface dysfunction — and most were unaware. This matters because undiagnosed pre-existing DED is one of the strongest predictors of severe post-operative symptoms.
The numbers also vary significantly by surgical technique. In comparative studies, the incidence of dry eye at one week post-operatively was 53% in SICS patients vs 22% in phacoemulsification patients — a stark difference driven by incision size and the corresponding amount of corneal nerve disruption.
Who is most likely
to develop it
Not all cataract patients face equal risk. These factors — identified across multiple studies — predict significantly higher likelihood of post-operative dry eye.
Symptoms — and their
impact on vision quality
The surface presentation is familiar: grittiness, burning, foreign body sensation, light sensitivity, fluctuating blur. Patients describe the feeling as sand in the eye, or like looking through frosted glass in the first weeks after what was supposed to be vision-improving surgery.
What is less appreciated is the visual impact of dry eye on optical quality. The tear film is the outermost refractive surface of the eye. When it is unstable — breaking up within seconds of a blink rather than the normal 10+ seconds — incoming light is scattered before it even reaches the IOL or the retina.
This matters clinically because patients sometimes attribute poor vision after cataract surgery to their IOL power, or to the surgical outcome, when the actual cause is an unstable tear film degrading optical quality. Studies by Goto et al. (2002) and Koh (2016) demonstrated measurable functional visual acuity impairment in dry eye patients using contrast sensitivity testing.
The misattribution problem — what surgeons hear vs what is happening
A patient who says "my vision is still blurry" three weeks after a technically perfect cataract surgery may be experiencing dry eye, not a refractive miss. Treating the ocular surface first — before any power adjustment or further intervention — resolves vision complaints in a significant proportion of cases. This is why post-operative dry eye assessment should be part of every follow-up, not an afterthought.
What actually helps —
and what the evidence says
Not all dry eye treatments are created equal. Here is what has evidence behind it, roughly in order of where to start.
-
1Preservative-free artificial tears — frequently, not sparinglyThe most important first-line intervention. Preservative-free formulations (sodium hyaluronate, carbomer, CMC-based) can be used every 30–60 minutes if needed without risk of toxicity. The key word is preservative-free — BAK-containing tears may temporarily relieve symptoms while adding to the underlying surface damage. Use them liberally. Use the right ones.First Line · Begin Day 1 Post-Op
-
2Warm compresses + lid hygiene (especially for MGD)If meibomian gland dysfunction is contributing — and it very commonly is in this age group — daily warm compresses (4 minutes, once or twice daily) combined with gentle lid margin cleaning improve meibum quality and tear film lipid layer stability. Low-tech, no side effects, genuinely effective. Often overlooked in favour of drops.First Line · Daily Routine
-
3Switch post-operative drops to preservative-free formulationsIf the surgeon's protocol uses preservative-containing antibiotics, anti-inflammatories, or NSAIDs, switching to preservative-free equivalents significantly reduces ocular surface toxicity. A 2025 Springer review (Di Zazzo et al., Cornea) supports prophylactic preservative-free treatment for patients at high risk of post-operative ocular surface disease.Clinical Decision · Surgeon-Led
-
4Diquafosol tetrasodium (preservative-free)Specifically highlighted in the 2022 Miura et al. meta-analysis as effective for preventing and treating post-cataract DED. Diquafosol stimulates both aqueous and mucin secretion — addressing multiple components of tear film instability. Not universally available but where it exists, evidence supports its use in post-operative patients.Evidence-Based · Where Available
-
5Cyclosporine A or lifitegrast for moderate-to-severe casesFor patients whose dry eye does not improve with lubricants and lid hygiene after 4–6 weeks, anti-inflammatory topical treatments address the underlying inflammatory cycle. Lifitegrast (Xiidra) was shown in the OPUS-1 study to reduce both symptoms and signs of moderate-to-severe DED. A 2020 study by Hovanesian et al. demonstrated that lifitegrast improved refractive accuracy in dry eye patients undergoing cataract surgery — evidence that starting it pre-operatively may improve outcomes.Second Line · For Persistent DED
-
6Pre-operative meibomian gland treatmentThe Miura 2022 meta-analysis identified pre-operative MGD treatment as one of two interventions with the clearest evidence for reducing post-operative dry eye. Treating MGD before surgery — with warm compresses, LipiFlow, or IPL therapy — reduces one of the primary risk factors. This is a surgeon-side decision but patients can ask about it at their pre-operative assessment.Pre-Operative · High Evidence
Intraoperative viscoelastics on the corneal surface — a surgeon-level intervention
A 2026 review in Nutrients (Management of Dry Eye Disease Pre- and Post-Cataract Surgery) highlighted that applying HPMC (hydroxypropyl methylcellulose) viscoelastic to the corneal surface during surgery — rather than BSS irrigation alone — reduced post-operative dry eye metrics. An RCT of 149 patients found HPMC improved Schirmer I scores and reduced corneal staining, particularly in patients with pre-existing DED. This is exactly the kind of evidence-based intraoperative decision that distinguishes surgeons who take post-cataract DED seriously from those who do not.
The standard of care gap — and why it matters for patients
In corneal refractive surgery — LASIK, PRK, SMILE — treating dry eye aggressively for 3–6 months after the procedure is considered standard of care. Every LASIK patient is counselled about it beforehand. Every LASIK patient gets lubricant drops from day one. The connection between corneal nerve disruption and dry eye is fully appreciated in that context.
Cataract surgery involves the same corneal nerve disruption — arguably in a patient population more vulnerable to dry eye than the typical refractive surgery candidate. And yet the aggressive dry eye management that is routine in LASIK is not consistently applied to cataract patients.
The Review of Ophthalmology editorial quoted above makes this point pointedly: these are older patients, often already predisposed to dry eye, having their corneal nerves cut, and then given pharmaceutical drops that can worsen the ocular surface. The standard of care should mirror what happens after refractive surgery. It frequently does not.
The practical implication for patients: if you are having cataract surgery and have any history of dry eye, ask your surgeon specifically about pre-operative ocular surface assessment, preservative-free post-operative drops, and what to do if dry eye symptoms persist beyond 4 weeks. A surgeon who takes this seriously will have a clear answer.
More from Beyond Vision
Continue your understanding of cataract surgery, IOLs, and visual recovery.
Frequently asked questions
The primary cause is corneal denervation — the surgical incision cuts through radial corneal nerve fibres that form the feedback loop between the eye surface and the lacrimal gland. When these nerves are severed, the signal to produce tears is reduced, reflex tearing drops, and blink frequency decreases. This is compounded by surgical inflammation, preservative toxicity from post-operative drops, microscope light exposure, and the eye being held open without blinking during surgery.
Severity typically peaks at 1–7 days post-operatively. For most patients, significant improvement occurs within 1–3 months as corneal nerves regenerate. High-risk patients — those with pre-existing DED, MGD, diabetes, or who had FLACS or bilateral sequential surgery — may experience symptoms for 6–12 months. A minority have symptoms beyond one year, particularly if underlying MGD or systemic disease was not addressed.
Yes, significantly. The tear film is the outermost refractive surface of the eye. An unstable tear film scatters incoming light before it reaches the IOL or retina, causing blurred, fluctuating vision, reduced contrast sensitivity, and difficulty with glare and halos. Many patients who report "blurry vision" after a technically successful cataract surgery are actually experiencing dry eye-related optical degradation. Treating the ocular surface often resolves these vision complaints.
Preservative-free artificial tears used frequently (every 1–2 hours if needed) are first line. Warm compresses help when MGD is a contributing factor. If post-operative drops contain preservatives, switching to preservative-free alternatives significantly reduces surface toxicity. For moderate-to-severe cases, anti-inflammatory treatments (cyclosporine A, lifitegrast) address the inflammatory cycle. The 2022 Miura meta-analysis found diquafosol tetrasodium and pre-operative meibomian gland treatment had the strongest evidence for prevention and treatment.
Yes — this is one of the most important pieces of pre-operative information you can provide. Pre-existing dry eye or MGD is one of the strongest predictors of severe post-operative symptoms. It also affects biometry accuracy: an unstable tear film changes corneal topography measurements, which can introduce errors in IOL power calculation. Surgeons who know about pre-existing DED can optimise the ocular surface before surgery, potentially switching to preservative-free drops, treating MGD first, and counselling patients about the expected recovery course.
The evidence suggests yes. A 2024 Toronto study found femtosecond laser-assisted cataract surgery was associated with higher odds of post-operative dry eye symptoms requiring follow-up compared to manual phacoemulsification. This may relate to additional corneal contact during laser docking, suction effects on the ocular surface, or inflammatory mediators released during femtosecond laser application. Patients choosing FLACS for other optical advantages should be counselled about this dry eye risk.
Peer-Reviewed References
- Miura M, Inomata T, et al. (2022). Prevalence and characteristics of dry eye disease after cataract surgery: a systematic review and meta-analysis. Ophthalmology and Therapy, 11(4), 1309–1332.
- Ta H, McCann P, et al. (2025). Dry eye post-cataract surgery: a systematic review and meta-analysis. BMC Ophthalmology, 25, 18. doi:10.1186/s12886-024-03841-8
- Yang F, et al. (2024). Health care utilization, prevalence, and risk factors of dry eyes after cataract surgery. Canadian Journal of Ophthalmology, 60(3), 150–155.
- Di Zazzo A, Spelta S, et al. (2025). Prophylactic therapy for long-term ocular discomfort after cataract surgery. Cornea, 44, 443–449.
- Hovanesian J, Epitropoulos A, Donnenfeld ED, et al. (2020). The effect of lifitegrast on refractive accuracy and symptoms in dry eye patients undergoing cataract surgery. Clinical Ophthalmology, 14, 2709–2716.
- Huang Y, et al. (2021). Dry eye and phacoemulsification cataract surgery: a systematic review and meta-analysis. Frontiers in Medicine, 8, 649030.
- Management of Dry Eye Disease Pre- and Post-Cataract Surgery: A Personalized Approach. (2026). Nutrients / MDPI. PMC12942407.
- Gupta PK, et al. (2018). Prevalence of ocular surface dysfunction in patients presenting for cataract surgery evaluation. Journal of Cataract & Refractive Surgery, 44, 1090–1096.
- Review of Ophthalmology — commentary on dry eye syndrome after cataract surgery (multiple issues, 2005–2024).
Precision surgery starts with a
healthy ocular surface.
Agaaz Ophthalmics manufactures OVDs, intracameral solutions, and surgical consumables that support optimal outcomes — including products designed to protect the ocular surface intraoperatively.
Dry Eye After
Cataract Surgery:
Why It Happens
and What Actually Helps
More than 1 in 3 people who have cataract surgery come out the other side with dry eyes. Not because something went wrong — but because of what surgery, by its very nature, does to the corneal nerves. Here's the full picture.
post-surgery (meta-analysis, 2022)
follow-up for dry eye symptoms
post-operatively
corneal nerves regenerate
- 1What dry eye after surgery actually is
- 2The corneal nerve — why surgery causes it
- 3How common it is: the real numbers
- 4Risk factors — who is most vulnerable
- 5Symptoms and vision impact
- 6What actually helps — treatment evidence
- 7What surgeons know (that patients often don't)
- 8Frequently asked questions
First, an honest admission
Cataract surgery has a 99%+ success rate. It restores vision. It is genuinely one of medicine's great miracles. And for more than a third of patients, it also causes dry eye.
These two things can both be true. A surgery can go perfectly and still leave a patient with gritty, burning, light-sensitive eyes for weeks or months. Understanding why this happens — the actual biology — changes how patients experience recovery and how surgeons manage expectations.
Dry eye after cataract surgery is not a complication in the traditional sense. It is not a sign that something went wrong. It is a predictable, physiologically explicable consequence of what every cataract surgery, no matter how skilled the surgeon, does to the corneal nervous system.
This article covers the mechanism, the numbers, the risk factors, and the treatments — drawing on peer-reviewed research from 2022 through 2026 rather than generic aftercare advice.
The corneal nerve: surgery's
unavoidable disruption
The cornea has the highest density of sensory nerve endings of any tissue in the human body. Every cataract incision — however small — cuts through some of them.
To understand why dry eye occurs after cataract surgery, you need to understand what those corneal nerves actually do. They are not there only for sensation. They form a feedback loop: they sense whether the ocular surface is dry, and if it is, they send signals to the lacrimal gland to produce more tears, and to the brain to trigger a blink.
When a surgeon makes a clear corneal incision — even a modern micro-incision of 2.0–2.8mm — those radial stromal nerve fibres at the incision site are severed. The feedback loop is interrupted. The lacrimal gland receives less signal. Reflex tearing drops. Blink frequency decreases without the normal neural prompts.
"Gather a group of patients who are prone to dry eye due to their age and co-existing systemic health issues. Now cut their corneal nerves, create inflammation, and then induce more ocular surface disruption via topical pharmaceuticals. Is there any wonder why these patients complain of dry eyes, ocular irritation, and foreign body sensation after cataract surgery?"
Four mechanisms operating simultaneously
Post-cataract dry eye is multifactorial. These factors compound each other.
SICS vs Phacoemulsification: incision size matters
Manual small incision cataract surgery (SICS), which uses a 5–7mm corneoscleral tunnel, severs a larger arc of corneal nerves than modern phacoemulsification (1.8–2.8mm). Studies consistently show higher dry eye prevalence and severity in the first weeks after SICS. However, phacoemulsification is not free of nerve disruption — even micro-incision techniques reduce corneal sensitivity measurably for up to 3 months post-operatively.
How common is it —
the actual numbers
Here is what the peer-reviewed literature says, as of 2025–2026:
37.4% — That is the pooled prevalence of dry eye disease in patients without pre-existing DED who underwent cataract surgery, from a systematic review and meta-analysis by Miura et al. published in Ophthalmology and Therapy (2022), which included nine studies covering 775 patients. Overall 37.4% (95% CI 22.6–52.3) of patients without preexisting DED developed dry eye disease after cataract surgery.
A separate 2025 meta-analysis from the University of Colorado (Ta et al., BMC Ophthalmology) confirmed that dry eye severity usually peaks at one week after cataract surgery and may persist for up to three months postoperatively.
From a healthcare utilisation standpoint, nearly 1 in 5 patients had dry eye symptoms post-cataract surgery requiring non-routine follow-up, with 1 in 12 needing more than one extra appointment — representing significant clinical burden beyond the expected recovery pathway.
The underdiagnosis problem
Dry eye is significantly underdiagnosed before cataract surgery. Many patients presenting for cataract evaluation already have subclinical DED that has not been identified. A 2018 study by Gupta et al. (Journal of Cataract and Refractive Surgery) found that 77% of patients presenting for cataract evaluation had signs of ocular surface dysfunction — and most were unaware. This matters because undiagnosed pre-existing DED is one of the strongest predictors of severe post-operative symptoms.
The numbers also vary significantly by surgical technique. In comparative studies, the incidence of dry eye at one week post-operatively was 53% in SICS patients vs 22% in phacoemulsification patients — a stark difference driven by incision size and the corresponding amount of corneal nerve disruption.
Who is most likely
to develop it
Not all cataract patients face equal risk. These factors — identified across multiple studies — predict significantly higher likelihood of post-operative dry eye.
Symptoms — and their
impact on vision quality
The surface presentation is familiar: grittiness, burning, foreign body sensation, light sensitivity, fluctuating blur. Patients describe the feeling as sand in the eye, or like looking through frosted glass in the first weeks after what was supposed to be vision-improving surgery.
What is less appreciated is the visual impact of dry eye on optical quality. The tear film is the outermost refractive surface of the eye. When it is unstable — breaking up within seconds of a blink rather than the normal 10+ seconds — incoming light is scattered before it even reaches the IOL or the retina.
This matters clinically because patients sometimes attribute poor vision after cataract surgery to their IOL power, or to the surgical outcome, when the actual cause is an unstable tear film degrading optical quality. Studies by Goto et al. (2002) and Koh (2016) demonstrated measurable functional visual acuity impairment in dry eye patients using contrast sensitivity testing.
The misattribution problem — what surgeons hear vs what is happening
A patient who says "my vision is still blurry" three weeks after a technically perfect cataract surgery may be experiencing dry eye, not a refractive miss. Treating the ocular surface first — before any power adjustment or further intervention — resolves vision complaints in a significant proportion of cases. This is why post-operative dry eye assessment should be part of every follow-up, not an afterthought.
What actually helps —
and what the evidence says
Not all dry eye treatments are created equal. Here is what has evidence behind it, roughly in order of where to start.
-
1Preservative-free artificial tears — frequently, not sparinglyThe most important first-line intervention. Preservative-free formulations (sodium hyaluronate, carbomer, CMC-based) can be used every 30–60 minutes if needed without risk of toxicity. The key word is preservative-free — BAK-containing tears may temporarily relieve symptoms while adding to the underlying surface damage. Use them liberally. Use the right ones.First Line · Begin Day 1 Post-Op
-
2Warm compresses + lid hygiene (especially for MGD)If meibomian gland dysfunction is contributing — and it very commonly is in this age group — daily warm compresses (4 minutes, once or twice daily) combined with gentle lid margin cleaning improve meibum quality and tear film lipid layer stability. Low-tech, no side effects, genuinely effective. Often overlooked in favour of drops.First Line · Daily Routine
-
3Switch post-operative drops to preservative-free formulationsIf the surgeon's protocol uses preservative-containing antibiotics, anti-inflammatories, or NSAIDs, switching to preservative-free equivalents significantly reduces ocular surface toxicity. A 2025 Springer review (Di Zazzo et al., Cornea) supports prophylactic preservative-free treatment for patients at high risk of post-operative ocular surface disease.Clinical Decision · Surgeon-Led
-
4Diquafosol tetrasodium (preservative-free)Specifically highlighted in the 2022 Miura et al. meta-analysis as effective for preventing and treating post-cataract DED. Diquafosol stimulates both aqueous and mucin secretion — addressing multiple components of tear film instability. Not universally available but where it exists, evidence supports its use in post-operative patients.Evidence-Based · Where Available
-
5Cyclosporine A or lifitegrast for moderate-to-severe casesFor patients whose dry eye does not improve with lubricants and lid hygiene after 4–6 weeks, anti-inflammatory topical treatments address the underlying inflammatory cycle. Lifitegrast (Xiidra) was shown in the OPUS-1 study to reduce both symptoms and signs of moderate-to-severe DED. A 2020 study by Hovanesian et al. demonstrated that lifitegrast improved refractive accuracy in dry eye patients undergoing cataract surgery — evidence that starting it pre-operatively may improve outcomes.Second Line · For Persistent DED
-
6Pre-operative meibomian gland treatmentThe Miura 2022 meta-analysis identified pre-operative MGD treatment as one of two interventions with the clearest evidence for reducing post-operative dry eye. Treating MGD before surgery — with warm compresses, LipiFlow, or IPL therapy — reduces one of the primary risk factors. This is a surgeon-side decision but patients can ask about it at their pre-operative assessment.Pre-Operative · High Evidence
Intraoperative viscoelastics on the corneal surface — a surgeon-level intervention
A 2026 review in Nutrients (Management of Dry Eye Disease Pre- and Post-Cataract Surgery) highlighted that applying HPMC (hydroxypropyl methylcellulose) viscoelastic to the corneal surface during surgery — rather than BSS irrigation alone — reduced post-operative dry eye metrics. An RCT of 149 patients found HPMC improved Schirmer I scores and reduced corneal staining, particularly in patients with pre-existing DED. This is exactly the kind of evidence-based intraoperative decision that distinguishes surgeons who take post-cataract DED seriously from those who do not.
The standard of care gap — and why it matters for patients
In corneal refractive surgery — LASIK, PRK, SMILE — treating dry eye aggressively for 3–6 months after the procedure is considered standard of care. Every LASIK patient is counselled about it beforehand. Every LASIK patient gets lubricant drops from day one. The connection between corneal nerve disruption and dry eye is fully appreciated in that context.
Cataract surgery involves the same corneal nerve disruption — arguably in a patient population more vulnerable to dry eye than the typical refractive surgery candidate. And yet the aggressive dry eye management that is routine in LASIK is not consistently applied to cataract patients.
The Review of Ophthalmology editorial quoted above makes this point pointedly: these are older patients, often already predisposed to dry eye, having their corneal nerves cut, and then given pharmaceutical drops that can worsen the ocular surface. The standard of care should mirror what happens after refractive surgery. It frequently does not.
The practical implication for patients: if you are having cataract surgery and have any history of dry eye, ask your surgeon specifically about pre-operative ocular surface assessment, preservative-free post-operative drops, and what to do if dry eye symptoms persist beyond 4 weeks. A surgeon who takes this seriously will have a clear answer.
More from Beyond Vision
Continue your understanding of cataract surgery, IOLs, and visual recovery.
Frequently asked questions
The primary cause is corneal denervation — the surgical incision cuts through radial corneal nerve fibres that form the feedback loop between the eye surface and the lacrimal gland. When these nerves are severed, the signal to produce tears is reduced, reflex tearing drops, and blink frequency decreases. This is compounded by surgical inflammation, preservative toxicity from post-operative drops, microscope light exposure, and the eye being held open without blinking during surgery.
Severity typically peaks at 1–7 days post-operatively. For most patients, significant improvement occurs within 1–3 months as corneal nerves regenerate. High-risk patients — those with pre-existing DED, MGD, diabetes, or who had FLACS or bilateral sequential surgery — may experience symptoms for 6–12 months. A minority have symptoms beyond one year, particularly if underlying MGD or systemic disease was not addressed.
Yes, significantly. The tear film is the outermost refractive surface of the eye. An unstable tear film scatters incoming light before it reaches the IOL or retina, causing blurred, fluctuating vision, reduced contrast sensitivity, and difficulty with glare and halos. Many patients who report "blurry vision" after a technically successful cataract surgery are actually experiencing dry eye-related optical degradation. Treating the ocular surface often resolves these vision complaints.
Preservative-free artificial tears used frequently (every 1–2 hours if needed) are first line. Warm compresses help when MGD is a contributing factor. If post-operative drops contain preservatives, switching to preservative-free alternatives significantly reduces surface toxicity. For moderate-to-severe cases, anti-inflammatory treatments (cyclosporine A, lifitegrast) address the inflammatory cycle. The 2022 Miura meta-analysis found diquafosol tetrasodium and pre-operative meibomian gland treatment had the strongest evidence for prevention and treatment.
Yes — this is one of the most important pieces of pre-operative information you can provide. Pre-existing dry eye or MGD is one of the strongest predictors of severe post-operative symptoms. It also affects biometry accuracy: an unstable tear film changes corneal topography measurements, which can introduce errors in IOL power calculation. Surgeons who know about pre-existing DED can optimise the ocular surface before surgery, potentially switching to preservative-free drops, treating MGD first, and counselling patients about the expected recovery course.
The evidence suggests yes. A 2024 Toronto study found femtosecond laser-assisted cataract surgery was associated with higher odds of post-operative dry eye symptoms requiring follow-up compared to manual phacoemulsification. This may relate to additional corneal contact during laser docking, suction effects on the ocular surface, or inflammatory mediators released during femtosecond laser application. Patients choosing FLACS for other optical advantages should be counselled about this dry eye risk.
Peer-Reviewed References
- Miura M, Inomata T, et al. (2022). Prevalence and characteristics of dry eye disease after cataract surgery: a systematic review and meta-analysis. Ophthalmology and Therapy, 11(4), 1309–1332.
- Ta H, McCann P, et al. (2025). Dry eye post-cataract surgery: a systematic review and meta-analysis. BMC Ophthalmology, 25, 18. doi:10.1186/s12886-024-03841-8
- Yang F, et al. (2024). Health care utilization, prevalence, and risk factors of dry eyes after cataract surgery. Canadian Journal of Ophthalmology, 60(3), 150–155.
- Di Zazzo A, Spelta S, et al. (2025). Prophylactic therapy for long-term ocular discomfort after cataract surgery. Cornea, 44, 443–449.
- Hovanesian J, Epitropoulos A, Donnenfeld ED, et al. (2020). The effect of lifitegrast on refractive accuracy and symptoms in dry eye patients undergoing cataract surgery. Clinical Ophthalmology, 14, 2709–2716.
- Huang Y, et al. (2021). Dry eye and phacoemulsification cataract surgery: a systematic review and meta-analysis. Frontiers in Medicine, 8, 649030.
- Management of Dry Eye Disease Pre- and Post-Cataract Surgery: A Personalized Approach. (2026). Nutrients / MDPI. PMC12942407.
- Gupta PK, et al. (2018). Prevalence of ocular surface dysfunction in patients presenting for cataract surgery evaluation. Journal of Cataract & Refractive Surgery, 44, 1090–1096.
- Review of Ophthalmology — commentary on dry eye syndrome after cataract surgery (multiple issues, 2005–2024).
Precision surgery starts with a
healthy ocular surface.
Agaaz Ophthalmics manufactures OVDs, intracameral solutions, and surgical consumables that support optimal outcomes — including products designed to protect the ocular surface intraoperatively.
Start writing here...
Dry Eye After Cataract Surgery: Why It Happens & What Helps 2026